Stock Analysis

Swedish Exchange Growth Companies With Up To 20% Insider Ownership

Source: Shutterstock

Amidst a backdrop of fluctuating global markets and economic uncertainties, Sweden's stock market presents a unique landscape for investors interested in growth companies with substantial insider ownership. Such companies often demonstrate strong alignment between management's interests and shareholder values, which can be particularly appealing in the current volatile market environment.

Top 10 Growth Companies With High Insider Ownership In Sweden

NameInsider OwnershipEarnings Growth
CTT Systems (OM:CTT)16.9%21.6%
BioArctic (OM:BIOA B)35.1%50.9%
Sileon (OM:SILEON)33.3%109.3%
Biovica International (OM:BIOVIC B)12.7%73.8%
KebNi (OM:KEBNI B)37.8%90.4%
Calliditas Therapeutics (OM:CALTX)11.6%52.9%
edyoutec (NGM:EDYOU)14.6%63.1%
Egetis Therapeutics (OM:EGTX)17.6%98.2%
Yubico (OM:YUBICO)37.5%43.4%
SaveLend Group (OM:YIELD)24.9%103.4%

Click here to see the full list of 84 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Let's dive into some prime choices out of from the screener.

Betsson (OM:BETS B)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Betsson AB (publ) operates primarily in the online gaming industry across various regions including the Nordic countries, Latin America, Western Europe, Central and Eastern Europe, and Central Asia, with a market capitalization of SEK 16.36 billion.

Operations: The company generates €974.50 million in revenue from its Casinos & Resorts segment.

Insider Ownership: 10.9%

Betsson, a Swedish company with significant insider ownership, shows promising growth prospects. Recently, Betsson reported a solid increase in Q1 sales to €248.2 million and net income to €41.3 million. Insiders have actively bought shares recently, underscoring confidence in the company's trajectory. Despite this, its revenue growth forecast of 9.9% per year is modest compared to some market leaders but outpaces the general Swedish market's 1.8%. However, Betsson trades at 70.3% below its estimated fair value and analysts expect a potential price rise of 27.2%, suggesting an undervaluation issue that could present opportunities for investors aware of the risks associated with unstable dividends and moderate earnings growth forecasts.

OM:BETS B Earnings and Revenue Growth as at Jun 2024
OM:BETS B Earnings and Revenue Growth as at Jun 2024

NIBE Industrier (OM:NIBE B)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: NIBE Industrier AB, a company based in Sweden, specializes in developing, manufacturing, marketing, and selling energy-efficient solutions for indoor climate comfort and intelligent heating and control across the Nordic countries, other parts of Europe, North America, and internationally. The company has a market capitalization of approximately SEK 98.26 billion.

Operations: NIBE Industrier's revenue is derived from three main segments: Stoves (SEK 5.62 billion), Element (SEK 13.62 billion), and Climate Solutions (SEK 36.83 billion).

Insider Ownership: 20.2%

NIBE Industrier, a Swedish growth company with high insider ownership, recently faced challenges with a significant drop in Q1 2024 sales to SEK 9.49 billion and shifted to a net loss of SEK 857 million from a profit last year. Despite this downturn, the company is poised for recovery with expected annual earnings growth of 27.6% and revenue growth of 6.1%, both surpassing the market averages in Sweden. The appointment of Simon Karlin, known for his role in global expansions at Beijer Ref, as head of NIBE Climate Solutions could further enhance strategic initiatives and competitiveness.

OM:NIBE B Earnings and Revenue Growth as at Jun 2024
OM:NIBE B Earnings and Revenue Growth as at Jun 2024

Vimian Group (OM:VIMIAN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vimian Group AB operates globally in the animal health sector and has a market capitalization of approximately SEK 18.16 billion.

Operations: Vimian Group's revenue is divided into several key segments: Medtech generates €109.03 million, Diagnostics contributes €21.14 million, Specialty Pharma brings in €153.26 million, and Veterinary Services accounts for €51.63 million.

Insider Ownership: 11%

Vimian Group, a Swedish growth company with high insider ownership, reported modest Q1 2024 earnings with EUR 91.3 million in sales and EUR 3.5 million in net income, reflecting slight revenue growth but a decrease in net income year-over-year. The recent board changes, including Magnus Welander's appointment as chairman, could influence strategic directions. Despite shareholder dilution last year, Vimian is trading below its estimated fair value and has seen more insider buying than selling recently. With earnings forecasted to grow significantly at 58.6% annually over the next three years, Vimian demonstrates potential amidst challenges like low forecasted return on equity and insufficient coverage of interest payments by earnings.

OM:VIMIAN Ownership Breakdown as at Jun 2024
OM:VIMIAN Ownership Breakdown as at Jun 2024

Seize The Opportunity

Want To Explore Some Alternatives?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're helping make it simple.

Find out whether Vimian Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email